Neo Hospital Group
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Neo Hospital Group - overview
Established
2018
Location
Krakow, -, Poland
Primary Industry
Healthcare
About
Based in Krakow, Poland, and founded in 2018, Neo Hospital Group operates as a modern medical organization specializing in robotic surgery and advanced healthcare services. In August 2025, Spire Capital invested in Neo Hospital Group. Neo Hospital Group operates Szpital na Klinach, the robotic surgery center and outpatient clinics. The company specializes in allergology, bariatrics – treatment of obesity, pediatric surgery, pediatric surgery, spine surgery, vascular surgery, general surgery, oncological surgery, plastic surgery, and many more.
Current Investors
Spire Capital
Primary Industry
Healthcare
Sub Industries
Hospitals, Optometrists & Opticians Products and Services, Oncology/Cancer Treatment, Mental Health Services, Dermatology, Dental Products & Services, Cardiology
Website
www.szpitalnaklinach.pl
Company Stage
Mature - Growth Capital
Total Amount Raised
Subscriber access only
Neo Hospital Group - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Growth | Completed | Neo Hospital Group | - |
Displaying 1 - 1 of 1

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.